| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.088 | 0.09 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.09 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |